https://orcid.org/0000-0002-2460-4808
References
- Lobstein T, Brinsden H, Neveux M. World obesity Atlas 2022. 2022.
- Holmbeck K, Bianco P, Caterina J, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999 October 01;99(1):81–92.
- Chun TH, Hotary KB, Sabeh F, et al. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell. 2006 May 5;125(3):577–591.
- Chun TH, Inoue M, Morisaki H, et al. Genetic link between obesity and MMP14-dependent adipogenic collagen turnover. Diabetes. 2010 October;59(10):2484–2494.
- Chow CFW, Guo X, Asthana P, et al. Body weight regulation via MT1-MMP-mediated cleavage of GFRAL. Nat Metab. 2022 February;4(2):203–212.
- Johnen H, Lin S, Kuffner T, et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med. 2007 November;13(11):1333–1340.
- Mullican SE, Lin-Schmidt X, Chin CN, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017 October;23(10):1150–1157.
- Emmerson PJ, Wang F, Du Y, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017 October;23(10):1215–1219.
- Yang L, Chang CC, Sun Z, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017 October;23(10):1158–1166.
- Hsu JY, Crawley S, Chen M, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017 October 12;550(7675):255–259.
- Patel S, Alvarez-Guaita A, Melvin A, et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 2019 March 5;29(3):707–718 e8.
- Chan KM, Wong HL, Jin G, et al. MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis. Dev Cell. 2012 June 12;22(6):1176–1190.
- Tassone E, Valacca C, Mignatti P. Membrane-type 1 matrix metalloproteinase downregulates fibroblast growth factor-2 binding to the cell surface and intracellular signaling. J Cell Physiol. 2015 February;230(2):366–377.
- Sugiyama N, Varjosalo M, Meller P, et al. FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex. Proc Natl Acad Sci U S A. 2010 September 7;107(36):15786–15791.
- Gomez-Ambrosi J, Gallego-Escuredo JM, Catalan V, et al. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. Clin Nutr. 2017 June;36(3):861–868.
- Guo X, Asthana P, Gurung S, et al. Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor. Nat Commun. 2022 June 29;13(1):3749.